Carregant...
RRx-001, A novel dinitroazetidine radiosensitizer
The ‘holy grail’ in radiation oncology is to improve the outcome of radiation therapy (RT) with a radiosensitizer—a systemic chemical/biochemical agent that additively or synergistically sensitizes tumor cells to radiation in the absence of significant toxicity. Similar to the oxygen effect, in whic...
Guardat en:
| Publicat a: | Invest New Drugs |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4859863/ https://ncbi.nlm.nih.gov/pubmed/26841903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-016-0326-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|